Genmab A/S Stock

Genmab A/S Shareholder Yield

The Shareholder Yield of Genmab A/S (GMAB.CO) as of Aug 13, 2026 is 2.43 %. In the previous year, Shareholder Yield was 3.25 % — a change of -25.17% (lower).

Shareholder Yield

2.43 %

YoY

-25.17%

Last updated:

Shareholder Yield of Genmab A/S is 2026 2.43 % . Shareholder Yield of Genmab A/S was 2025 3.25 % . It decreases by -25.17% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Shareholder Yield of Genmab A/S is 2.43 % in 2026.

Shareholder Yield of Genmab A/S changed from 3.25 % to 2.43 %, representing a -25.17% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Shareholder Yield Genmab A/S since 2006 – with annual values, charts, and detailed analysis.

Shareholder yield combines dividend yield and buyback yield to show the total cash return to shareholders. It captures both dividends and share repurchases.

To evaluate Shareholder Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Shareholder Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Shareholder Yield's Genmab A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Genmab A/S

All Key Metrics — Genmab A/S